Treating Depressive Symptoms Among Veterans in Primary Care: A Multi-site RCT of Brief Behavioral Activation
Overview
Authors
Affiliations
Background: Behavioral activation is ideal for embedded behavioral health providers (BHPs) working in primary care settings treating patients reporting a range of depressive symptoms. The current study tested whether a brief version of Behavioral Activation (two 30-minute appointments, 2 boosters) designed for primary care (BA-PC) was more effective than primary care behavioral health treatment-as-usual (TAU) in reducing depressive symptoms and improving quality of life and functioning.
Methods: Parallel-arm, multi-site randomized controlled trial. 140 Veterans were randomized to BA-PC or TAU and completed assessments at baseline, 6 weeks, 12 weeks, and 24 weeks.
Results: Reductions in depressive symptoms were observed in both groups between baseline and 3-weeks prior to any treatment, with continued reductions among those in the BA-PC condition through 12-weeks. However, there was no significant condition X time interaction at 12-weeks. Quality of life and mental health functioning were significantly improved for those in the BA-PC condition, compared to TAU, at 12 weeks.
Limitations: Generalizability to a broader population may be limited as this sample consisted of veterans. Although engagement in TAU matched other prior work, it was lower than engagement in BA-PC, which also may compromise results.
Conclusions: Although this study found that both TAU and BA-PC participants showed a decline in depressive symptoms, improvements in functioning and quality of life within those assigned to BA-PC, strong treatment retention and feasibility of BA-PC, and significant reductions in depressive symptoms among those with more severe baseline depressive symptoms are encouraging and support continued research on BA-PC. This trial was registered in clinicaltrials.gov as Improving Mood in Veterans in Primary Care (NCT02276807).
Bystrom E, Wennlof B, Johansson I, Lonnberg L, Arkkukangas M, Pellas J Trials. 2024; 25(1):659.
PMID: 39369239 PMC: 11453080. DOI: 10.1186/s13063-024-08521-y.
Qin N, Luo Y, Wang S, Li Y, Li J, Luo J BMJ Open. 2024; 14(6):e086489.
PMID: 38925704 PMC: 11202641. DOI: 10.1136/bmjopen-2024-086489.
Shepardson R, Fletcher T, Funderburk J, Weisberg R, Beehler G, Maisto S Psychol Serv. 2022; 20(4):709-722.
PMID: 35951391 PMC: 10166237. DOI: 10.1037/ser0000696.
Gum A, Jensen C, Schonfeld L, Conner K, Guerra L J Clin Psychol Med Settings. 2022; 30(1):17-27.
PMID: 35220524 PMC: 8882215. DOI: 10.1007/s10880-022-09864-x.
Pellas J, Renner F, Ji J, Damberg M Int J Geriatr Psychiatry. 2021; 37(1).
PMID: 34729823 PMC: 8646381. DOI: 10.1002/gps.5646.